Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.821676
Abstract: Acute myeloid leukemia (AML) is an aggressive, heterogeneous group of malignancies with different clinical behaviors and different responses to therapy. For many types of cancer, finding cancer early makes it easier to treat. Identifying prognostic… read more here.
Keywords: molecular remission; promyelocytic leukemia; leukemia; treatment ... See more keywords
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15041349
Abstract: Simple Summary In this review, we discussed the impact of novel immune therapies on the treatment of child and adult acute lymphoblastic leukemia (ALL). Based on the promising results achieved in the relapsed/refractory (R/R) setting,… read more here.
Keywords: cell; molecular remission; optimal use; remission ... See more keywords